This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Hang on a second…

This CME Activity has expired and is no longer available for credit.

An Individualized Approach to Persistent OAB Symptoms

An Individualized Approach to Persistent OAB Symptoms



Time to Complete

30 minutes


January 12, 2018


January 11, 2019
Add to Queue

Maximum Credits

0.50 / AMA PRA Category 1 Credit(s)TM

Accredited Provider

Provided by Haymarket Medical Education (HME)

Commercial Supporter

Supported by Astellas Pharma US, Inc.

Program Description

Overactive bladder (OAB) is a common urologic condition that may impair quality of life, taking a significant toll on a number of health domains. While a number of safe and effective treatments for OAB exist, discontinuation rates of up to 90% have been reported within the first year of therapy. Unsatisfactory treatment outcome is, unfortunately, a common occurrence for patients with OAB who are treated with first-line therapy.

In this activity, a urologist and a primary care physician discuss care options for a 69-year-old woman with OAB who has discontinued treatment with an antimuscarinic agent due to bothersome side effects. The faculty will review second-line treatment options for this individual, including combination therapy. Third-line and investigational OAB treatment options are also discussed.

Intended Audience

Urologists, urologic healthcare professionals, primary care clinicians (MDs/DOs, PAs, NPs) and OB-GYNs

Educational Objectives

After completing the activity, the participant should be better able to:

  • Implement evidence-based guidelines for the management of OAB
  • Employ individualized treatment strategies for a patient with persistent OAB symptoms who discontinued first-line therapy because of adverse events

Conflict Of Interest Disclosure Policy

In accordance with the ACCME Standards for Commercial Support, HME requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational activities.


Matt T. Rosenberg, MD
Medical Director
Mid-Michigan Health Centers
Jackson, MI

Dr. Rosenberg is a consultant and stock holder for OPKD and serves on the Speaker’s Bureau for Astellas.

Evgeniy I. Kreydin, MD
Assistant Professor of Clinical of Urology
UC Keck School of Medicine Los Angeles
Los Angeles, CA

Dr. Kreydin has no relevant financial relationships to disclose.

Accredited Provider Disclosures

Haymarket Medical Education staff involved in the planning and content review of this activity have no relevant financial relationships to disclose.




AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Haymarket Medical Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient's medical condition.


The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Haymarket Medical Education or Astellas Pharma US, Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


In order to receive credit for this activity, the participant must complete the pre-activity questionnaire, post-test, and program evaluation. Participants must also score at least 70% on the post-test. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

If you have any questions relating to the accreditation of this activity, please contact

If you have any other questions relating to your certificate or other issues with the activity, please contact

Privacy Policy


Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue